Drug profile · INN
flurazepam hydrochloride
FLURAZEPAM HYDROCHLORIDE
flurazepam hydrochloride (FLURAZEPAM HYDROCHLORIDE) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — flurazepam hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
flurazepam hydrochloride (FLURAZEPAM HYDROCHLORIDE) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flurazepam hydrochloride?
flurazepam hydrochloride (FLURAZEPAM HYDROCHLORIDE) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for flurazepam hydrochloride?
FLURAZEPAM HYDROCHLORIDE is a marketed brand name for flurazepam hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flurazepam hydrochloride?
flurazepam hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.